Dr. Daniel G. Stover, MD
Claim this profileOhio State University Comprehensive Cancer Center
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
14 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Daniel G. Stover, MD is currently running
Educational Video
for Cancer Understanding
This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with metastatic cancer may help doctors provide patient-centered care by effectively communicating the importance of tumor genomic testing.
Recruiting1 award N/A3 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
More about Daniel G. Stover, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Daniel G. Stover, MD has experience with
- Pembrolizumab
- Decitabine
- Cyclophosphamide
- Paclitaxel
- Carboplatin
- Mammaglobin-A DNA Vaccine
Breakdown of trials Daniel G. Stover, MD has run
Breast Cancer
Cancer
Breast cancer
Lung Cancer
HER2 Negative
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel G. Stover, MD specialize in?
Daniel G. Stover, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Daniel G. Stover, MD currently recruiting for clinical trials?
Yes, Daniel G. Stover, MD is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Daniel G. Stover, MD has studied deeply?
Yes, Daniel G. Stover, MD has studied treatments such as Pembrolizumab, Decitabine, Cyclophosphamide.
What is the best way to schedule an appointment with Daniel G. Stover, MD?
Apply for one of the trials that Daniel G. Stover, MD is conducting.
What is the office address of Daniel G. Stover, MD?
The office of Daniel G. Stover, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.